-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Kairos Pharma, LTD. annual/quarterly Operating Income (Loss) history and growth rate from 2023 to 2024.
- Kairos Pharma, LTD. Operating Income (Loss) for the quarter ending September 30, 2024 was -$383K, a 33.4% decline year-over-year.
- Kairos Pharma, LTD. annual Operating Income (Loss) for 2024 was -$2.34M, a 36.7% decline from 2023.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)